# EDGAR Filing Document

**Accession Number:** 0002085975
**File Stem:** 0001628280-25-042680
**Filing Date:** 2025-9
**Character Count:** 16472
**Document Hash:** b0dec1726ec2f3f24f924299daba57b0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-042680.hdr.sgml**: 20250924

**ACCESSION NUMBER**: 0001628280-25-042680

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250922

**FILED AS OF DATE**: 20250924

**DATE AS OF CHANGE**: 20250924

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Alder Melanie
- **CENTRAL INDEX KEY:** 0002085981

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42852
- **FILM NUMBER:** 251340073

**MAIL ADDRESS:**
- **STREET 1:** C/O PATTERN GROUP INC.
- **STREET 2:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Alder Irrevocable Trust
- **CENTRAL INDEX KEY:** 0002085975

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** UT
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42852
- **FILM NUMBER:** 251340071

**BUSINESS ADDRESS:**
- **STREET 1:** C/O PATTERN GROUP INC.
- **STREET 2:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
- **BUSINESS PHONE:** (866) 765-1355

**MAIL ADDRESS:**
- **STREET 1:** C/O PATTERN GROUP INC.
- **STREET 2:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wright David K.
- **CENTRAL INDEX KEY:** 0002086238

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42852
- **FILM NUMBER:** 251340074

**MAIL ADDRESS:**
- **STREET 1:** C/O PATTERN GROUP INC.
- **STREET 2:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wright Irrevocable Trust
- **CENTRAL INDEX KEY:** 0002086236

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** UT
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42852
- **FILM NUMBER:** 251340072

**BUSINESS ADDRESS:**
- **STREET 1:** C/O PATTERN GROUP INC.
- **STREET 2:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
- **BUSINESS PHONE:** (866) 765-1355

**MAIL ADDRESS:**
- **STREET 1:** C/O PATTERN GROUP INC.
- **STREET 2:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pattern Group Inc.
- **CENTRAL INDEX KEY:** 0001811935
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-CATALOG & MAIL-ORDER HOUSES [5961]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 832556861
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043
- **BUSINESS PHONE:** 866-765-1355

**MAIL ADDRESS:**
- **STREET 1:** 1441 WEST INNOVATION WAY, SUITE 500
- **CITY:** LEHI
- **STATE:** UT
- **ZIP:** 84043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Covalent Group, Inc.
- **DATE OF NAME CHANGE:** 20200513

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wright David K.<br><sub>(Last) (First) (Middle)</sub><br>C/O PATTERN GROUP INC.<br>1441 WEST INNOVATION WAY, SUITE 500<br><sub>(Street)</sub><br>LEHI, UT 84043<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-09-22 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Pattern Group Inc. [ PTRN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Alder Melanie<br><sub>(Last) (First) (Middle)</sub><br>C/O PATTERN GROUP INC.<br>1441 WEST INNOVATION WAY, SUITE 500<br><sub>(Street)</sub><br>LEHI, UT 84043<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-09-22 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Strategy Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Pattern Group Inc. [ PTRN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wright Irrevocable Trust<br><sub>(Last) (First) (Middle)</sub><br>C/O PATTERN GROUP INC.<br>1441 WEST INNOVATION WAY, SUITE 500<br><sub>(Street)</sub><br>LEHI, UT 84043<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-09-22 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Pattern Group Inc. [ PTRN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Alder Irrevocable Trust<br><sub>(Last) (First) (Middle)</sub><br>C/O PATTERN GROUP INC.<br>1441 WEST INNOVATION WAY, SUITE 500<br><sub>(Street)</sub><br>LEHI, UT 84043<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-09-22 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Pattern Group Inc. [ PTRN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-09-22 |  | J<sup>(1)</sup> |  | 292781 | D | <sup>(1)</sup> | 0 | D |  |
| Series A Common Stock | 2025-09-22 |  | J<sup>(1)</sup> |  | 292781 | A | <sup>(1)</sup> | 292781 | D |  |
| Common Stock | 2025-09-22 |  | J<sup>(1)</sup> |  | 97593 | D | <sup>(1)</sup> | 0 | I | By spouse<sup>(2)</sup> |
| Series A Common Stock | 2025-09-22 |  | J<sup>(1)</sup> |  | 97593 | A | <sup>(1)</sup> | 97593 | I | By spouse<sup>(2)</sup> |
| Series A Common Stock | 2025-09-22 |  | J<sup>(3)</sup> |  | 50991951 | A | <sup>(3)</sup> | 50991951 | I | By Wright Irrevocable Trust<sup>(4)</sup> |
| Series A Common Stock | 2025-09-22 |  | S<sup>(5)</sup> |  | 5694671 | D | 13.02<sup>(5)</sup> | 45297280 | I | By Wright Irrevocable Trust<sup>(4)</sup> |
| Series A Common Stock | 2025-09-22 |  | J<sup>(3)</sup> |  | 33138200 | A | <sup>(3)</sup> | 33138200 | I | By Alder Irrevocable Trust<sup>(6)</sup> |
| Series A Common Stock | 2025-09-22 |  | S<sup>(5)</sup> |  | 3719615 | D | 13.02<sup>(5)</sup> | 29418585 | I | By Alder Irrevocable Trust<sup>(6)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Founder Non-Voting Preferred Stock | <sup>(7)</sup> | 2025-09-22 |  | J<sup>(3)</sup> |  |  | 41817539 | <sup>(7)</sup> | <sup>(7)</sup> | See footnotes<sup>(3)(7)</sup> | 50991951<sup>(3)</sup> | <sup>(3)</sup> | 0 | I | By Wright Irrevocable Trust<sup>(4)</sup> |
| Founder Non-Voting Preferred Stock | <sup>(7)</sup> | 2025-09-22 |  | J<sup>(3)</sup> |  |  | 27176014 | <sup>(7)</sup> | <sup>(7)</sup> | See footnotes<sup>(3)(7)</sup> | 33138200<sup>(3)</sup> | <sup>(3)</sup> | 0 | I | By Alder Irrevocable Trust<sup>(6)</sup> |
| Founder Voting Preferred Stock | <sup>(8)</sup> | 2025-09-22 |  | J<sup>(9)</sup> |  |  | 10682278 | <sup>(8)</sup> | <sup>(8)</sup> | See footnotes<sup>(8)(9)</sup> | 13025878<sup>(9)</sup> | <sup>(9)</sup> | 0 | D |  |
| Series B Common Stock | <sup>(10)</sup> | 2025-09-22 |  | J<sup>(9)</sup> |  | 13025878 |  | <sup>(10)</sup> | <sup>(10)</sup> | Series A Common Stock | 13025878 | <sup>(10)</sup> | 13025878 | D |  |
| Founder Voting Preferred Stock | <sup>(8)</sup> | 2025-09-22 |  | J<sup>(9)</sup> |  |  | 7115543 | <sup>(8)</sup> | <sup>(8)</sup> | See footnotes<sup>(8)(9)</sup> | 8676632<sup>(9)</sup> | <sup>(9)</sup> | 0 | I | By spouse<sup>(2)</sup> |
| Series B Common Stock | <sup>(10)</sup> | 2025-09-22 |  | J<sup>(9)</sup> |  | 8676632 |  | <sup>(10)</sup> | <sup>(10)</sup> | Series A Common Stock | 8676632 | <sup>(10)</sup> | 8676632 | I | By spouse<sup>(2)</sup> |

---

### Footnotes:

(1) Pursuant to a reclassification exempt under Rule 16b-7 of the Securities Exchange Act of 1934, as amended, each share of Common Stock, $0.001 par value per share ("Common Stock"), was reclassified into one share of Series A Common Stock, $0.001 par value per share ("Series A Common Stock"), immediately prior to the completion of the Issuer's initial public offering of Series A Common Stock (the "Offering").

(2) David K. Wright's spouse, Melanie Alder, is a director and the Chief Strategy Officer of the Issuer.

(3) Each share of Founder Non-Voting Preferred Stock was reclassified into 1.219391493 shares of Series A Common Stock immediately prior to the completion of the Offering.

(4) These shares are owned directly by the Wright Irrevocable Trust dated December 5, 2019, of which David K. Wright and his spouse, Melanie Alder, are trustees. Each of David K. Wright and Melanie Alder disclaims beneficial ownership of these securities, except to the extent, if any, of their pecuniary interest therein, and the filing of this Form 4 is not an admission that any person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

(5) The shares were sold in the Offering pursuant to an underwriting agreement by and among the Issuer, the representatives of the underwriters and the selling stockholders named therein, dated September 18, 2025.  The price of $13.02 represents the $14.00 Offering price per share of Series A Common Stock of the Issuer less the underwriting discounts and commissions of $0.98 per share, for shares sold to the underwriters pursuant to the Offering.

(6) These shares are owned directly by the Alder Irrevocable Trust dated December 5, 2019, of which David K. Wright and his spouse, Melanie Alder, are trustees. Each of David K. Wright and Melanie Alder disclaims beneficial ownership of these securities, except to the extent, if any, of their pecuniary interest therein, and the filing of this Form 4 is not an admission that any person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

(7) Each share of Founder Non-Voting Preferred Stock was convertible into, subject to certain anti-dilution adjustments dependent on the Offering price, (i) one share of Common Stock or (ii) in contemplation of an Offering, one share of Founder Voting Preferred Stock, at any time at the option of the holder. The shares of Founder Non-Voting Preferred Stock had no expiration date.

(8) Each share of Founder Voting Preferred Stock was convertible into, subject to certain anti-dilution adjustments dependent on the Offering price, (i) one share of Common Stock or (ii) one share of Founder Non-Voting Preferred Stock, at any time at the option of the holder. The shares of Founder Voting Preferred Stock had no expiration date.

(9) Each share of Founder Voting Preferred Stock was reclassified into 1.219391493 shares of Series B Common Stock immediately prior to the completion of the Offering.

(10) Each share of Series B Common Stock is convertible into one share of Series A Common Stock at the option of the holder at any time. Each share of Series B Common Stock will automatically convert into one share of Series A Common Stock upon certain transfers and the occurrence of certain events described in the Issuer's amended and restated certificate of incorporation.

**Signature:** DAVID K. WRIGHT By: /s/ Allison Fletcher, Attorney-in-Fact for David K. Wright  
**Date:** 2025-09-24

**Signature:** MELANIE ALDER By: /s/ Allison Fletcher, Attorney-in-Fact for Melanie Alder  
**Date:** 2025-09-24

**Signature:** WRIGHT IRREVOCABLE TRUST By: /s/ Allison Fletcher, Attorney-in-Fact for David K. Wright, Trustee By: /s/ Allison Fletcher, Attorney-in-Fact for Melanie Alder, Trustee  
**Date:** 2025-09-24

**Signature:** ALDER IRREVOCABLE TRUST By: /s/ Allison Fletcher, Attorney-in-Fact for David K. Wright, Trustee By: /s/ Allison Fletcher, Attorney-in-Fact for Melanie Alder, Trustee  
**Date:** 2025-09-24

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**